{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T23:35:09Z","timestamp":1771630509113,"version":"3.50.1"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience Letters"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.neulet.2016.04.057","type":"journal-article","created":{"date-parts":[[2016,4,30]],"date-time":"2016-04-30T11:27:12Z","timestamp":1462015632000},"page":"63-70","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Dose-dependent neuroprotective effect of caffeine on a rotenone-induced rat model of parkinsonism: A histological study"],"prefix":"10.1016","volume":"623","author":[{"given":"Amira M.","family":"Soliman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed M.","family":"Fathalla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed A.","family":"Moustafa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.neulet.2016.04.057_bib0005","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/j.1471-4159.1971.tb11966.x","article-title":"Histochemistry of myelin. XII. Anionic strainingof myelin basic roteins for histology, electrophoresis andelectron microscopy","volume":"18","author":"Adams","year":"1971","journal-title":"J. Neurochem."},{"issue":"October (1)","key":"10.1016\/j.neulet.2016.04.057_bib0010","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0166-4328(02)00180-8","article-title":"Rotenone destroys dopaminergic neurons and induces parkinsonian symptoms in rats","volume":"136","author":"Alam","year":"2002","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neulet.2016.04.057_bib0015","doi-asserted-by":"crossref","first-page":"986","DOI":"10.2741\/2119","article-title":"Mitochondrial toxins and neurodegenerative diseases","volume":"12","author":"Ayala","year":"2007","journal-title":"Front. Biosci."},{"key":"10.1016\/j.neulet.2016.04.057_bib0020","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.neuint.2015.11.006","article-title":"Neuroprotective effects of caffeine in MPTP model of Parkinson's disease: a (13)C NMR study","volume":"92","author":"Bagga","year":"2016","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neulet.2016.04.057_bib0025","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1038\/81834","article-title":"Chronic systemic pesticide exposure reproduces features of Parkinson\u2019s disease","volume":"3","author":"Betarbet","year":"2000","journal-title":"Nat. Neurosci."},{"issue":"2","key":"10.1016\/j.neulet.2016.04.057_bib0030","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.nbd.2009.01.016","article-title":"A highly reproducible rotenone model of Parkinson\u2019s disease","volume":"34","author":"Cannon","year":"2009","journal-title":"Neurobiol. Dis."},{"issue":"1","key":"10.1016\/j.neulet.2016.04.057_bib0035","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1093\/aje\/kwm260","article-title":"Peripheral inflammatory biomarkers and risk of Parkinson\u2019s disease","volume":"167","author":"Chen","year":"2008","journal-title":"Am. J. Epidemiol."},{"issue":"10","key":"10.1016\/j.neulet.2016.04.057_bib0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1523\/JNEUROSCI.21-10-j0001.2001","article-title":"Neuroprotection by caffeine and A(2A) adenosine receptor inactivation in a model of Parkinson\u2019s disease","volume":"21","author":"Chen","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neulet.2016.04.057_bib0045","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1007\/s12311-010-0196-3","article-title":"Purinergic modulation of granule cells","volume":"11","author":"Courjaret","year":"2012","journal-title":"Cerebellum"},{"issue":"8","key":"10.1016\/j.neulet.2016.04.057_bib0050","first-page":"976","article-title":"Gut feelings about smoking and coffee in Parkinson\u2019s disease","volume":"29","author":"Derkinderen","year":"2014","journal-title":"MovDisord"},{"key":"10.1016\/j.neulet.2016.04.057_bib0055","unstructured":"R.A. Drury, E.A. Wallington, Carleton\u2019s histological techniques. 4th ed. 1967. 214-215."},{"key":"10.1016\/j.neulet.2016.04.057_bib0060","first-page":"653","volume":"1","author":"Drury","year":"1980"},{"issue":"1","key":"10.1016\/j.neulet.2016.04.057_bib0065","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1602\/neurorx.1.1.139","article-title":"Neurodegeneration and neuroprotection in Parkinson disease","volume":"1","author":"Fahn","year":"2004","journal-title":"NeuroRx"},{"key":"10.1016\/j.neulet.2016.04.057_bib0070","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3389\/fnbeh.2016.00035","article-title":"Adenosine A2A receptor blockade prevents rotenone-induced motor impairment in a rat model of parkinsonism","volume":"10","author":"Fathalla","year":"2016","journal-title":"Front. Behav. Neurosci."},{"issue":"4","key":"10.1016\/j.neulet.2016.04.057_bib0075","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1111\/j.1471-4159.2007.05196.x","article-title":"An update on the mechanisms of the psychostimulant effects of caffeine","volume":"105","author":"Ferr\u00e9","year":"2008","journal-title":"J. Neurochem."},{"issue":"1","key":"10.1016\/j.neulet.2016.04.057_bib0080","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0031-6997(24)01396-6","article-title":"Actions of caffeine in the brain with special reference to factors that contribute to its widespread use","volume":"51","author":"Fredholm","year":"1999","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.neulet.2016.04.057_bib0085","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1002\/jnr.22366","article-title":"Adenosine A2A receptor but not HIF-1 mediates tyrosine hydroxylase induction in hypoxic PC12 cells","volume":"88","author":"Gammella","year":"2010","journal-title":"J. Neurosci. Res."},{"issue":"10","key":"10.1016\/j.neulet.2016.04.057_bib0090","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1152\/jn.00528.2011","article-title":"Adenosine inhibits glutamatergic input to basal forebarin cholinergic neurons","volume":"107","author":"Hawryluk","year":"2012","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.neulet.2016.04.057_bib0095","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1038\/nn1265","article-title":"Dopamine depletion impairs precursor cell proliferation in Parkinson disease","volume":"7","author":"Hoglinger","year":"2004","journal-title":"Nat. Neurosci."},{"issue":"6","key":"10.1016\/j.neulet.2016.04.057_bib0100","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1517\/13543784.14.6.729","article-title":"Istradefylline, a novel adenosine A2A receptor antagonist, for the treatment of Parkinson\u2019s disease","volume":"14","author":"Jenner","year":"2005","journal-title":"Expert Opin. Invest. Drugs"},{"key":"10.1016\/j.neulet.2016.04.057_bib0105","series-title":"From Molecules to Networks: An Introduction to Cellular and Molecular Neuroscience","first-page":"20","author":"John","year":"2009"},{"key":"10.1016\/j.neulet.2016.04.057_bib0110","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jchemneu.2015.11.002","article-title":"Investigation of tyrosine hydroxylase and BDNF in a low-dose rotenone model of Parkinson's disease","volume":"70","author":"Johnson","year":"2015","journal-title":"J. Chem. Neuroanat."},{"issue":"2","key":"10.1016\/j.neulet.2016.04.057_bib0115","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.expneurol.2010.02.007","article-title":"Caffeine protects against combined paraquat and maneb-induced dopaminergic neuron degeneration","volume":"223","author":"Kachroo","year":"2010","journal-title":"Exp. Neurol."},{"issue":"1\u20132","key":"10.1016\/j.neulet.2016.04.057_bib0120","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jns.2006.05.003","article-title":"Novel neuroprotection by caffeine and adenosine A(2A) receptor antagonists in animal models of Parkinson\u2019s disease","volume":"248","author":"Kalda","year":"2006","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.neulet.2016.04.057_bib0125","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.brainres.2007.10.055","article-title":"Histological evidence for drug diffusion across the cerebral meninges into the underlying neocortex in rats","volume":"1188","author":"Ludvig","year":"2008","journal-title":"Brain Res."},{"key":"10.1016\/j.neulet.2016.04.057_bib0130","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.bbr.2014.01.051","article-title":"Caffeine neuroprotective effects on 6-OHDA-lesioned rats are mediated by several factors, including pro-inflammatory cytokines and histone deacetylase inhibitions","volume":"264","author":"Machado-Filho","year":"2014","journal-title":"Behav. Brain Res."},{"issue":"12","key":"10.1016\/j.neulet.2016.04.057_bib0135","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/S1074-5521(00)00047-8","article-title":"Combinatorial synthesis of novel and potent inhibitors of NADH: ubiquinone oxidoreductase","volume":"7","author":"Nicolaou","year":"2000","journal-title":"Chem. Biol."},{"key":"10.1016\/j.neulet.2016.04.057_bib0140","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.neulet.2004.03.072","article-title":"Preventive effect of antioxidants in MPTP-induced mouse model of Parkinson\u2019s disease","volume":"363","author":"Park","year":"2004","journal-title":"Neurosci. Lett."},{"issue":"1-2","key":"10.1016\/j.neulet.2016.04.057_bib0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.lfs.2014.01.083","article-title":"Using caffeine and other adenosine receptor antagonists and agonists as therapeutic tools against neurodegenerative diseases: a review?","volume":"101","author":"Rivera-Oliver","year":"2014","journal-title":"Life Sci."},{"issue":"2","key":"10.1016\/j.neulet.2016.04.057_bib0150","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.expneurol.2012.01.022","article-title":"Delayed caffeine treatment prevents nigral dopamine neuron loss in a progressive rat model of Parkinson\u2019s disease","volume":"234","author":"Sonsalla","year":"2012","journal-title":"Exp. Neurol."},{"issue":"2","key":"10.1016\/j.neulet.2016.04.057_bib0155","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0006-8993(00)02960-7","article-title":"Increased striatal dopamine turnover following acute administration of rotenone to mice","volume":"885","author":"Thiffault","year":"2000","journal-title":"Brain Res."},{"issue":"9","key":"10.1016\/j.neulet.2016.04.057_bib0160","first-page":"507","article-title":"Altered expression patterns of inflammation-Associated and trophic molecules in substantia nigra and striatum brain samples from Parkinson\u2019s disease, incidental lewy body disease and normal control cases","volume":"14","author":"Walker","year":"2016","journal-title":"Front. Neurosci."},{"issue":"1","key":"10.1016\/j.neulet.2016.04.057_bib0165","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.neuroscience.2006.04.047","article-title":"Role of adenosine A1 receptors in the modulation of dopamine D1 and adenosine A2A receptor signaling in the neostriatum?","volume":"141","author":"Yabuuchi","year":"2006","journal-title":"Neuroscience"},{"issue":"2012","key":"10.1016\/j.neulet.2016.04.057_bib0170","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.pbb.2011.09.002","article-title":"Acetyl-L-carnitine and \u03b1-lipoic acid affect rotenone-induced damage in nigral dopaminergic neurons of rat brain, implication for Parkinson's disease therapy","volume":"100","author":"Zaitone","year":"2012","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"4","key":"10.1016\/j.neulet.2016.04.057_bib0175","doi-asserted-by":"crossref","first-page":"350","DOI":"10.2174\/187152712800792901","article-title":"Overview of tyrosine hydroxylase in Parkinson\u2019s disease","volume":"11","author":"Zhu","year":"2012","journal-title":"CNS Neurol. Disord. Drug Targets"}],"container-title":["Neuroscience Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394016302798?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394016302798?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T23:18:19Z","timestamp":1748906299000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304394016302798"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":35,"alternative-id":["S0304394016302798"],"URL":"https:\/\/doi.org\/10.1016\/j.neulet.2016.04.057","relation":{},"ISSN":["0304-3940"],"issn-type":[{"value":"0304-3940","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dose-dependent neuroprotective effect of caffeine on a rotenone-induced rat model of parkinsonism: A histological study","name":"articletitle","label":"Article Title"},{"value":"Neuroscience Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neulet.2016.04.057","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}